XTANT MEDICAL HOLDINGS INC (XTNT) Stock Price & Overview
NYSEARCA:XTNT • US98420P3082
Current stock price
The current stock price of XTNT is 0.621 USD. Today XTNT is up by 2.87%. In the past month the price increased by 6.46%. In the past year, price increased by 29.38%.
XTNT Key Statistics
- Market Cap
- 86.94M
- P/E
- 62.10
- Fwd P/E
- 121.76
- EPS (TTM)
- 0.01
- Dividend Yield
- N/A
XTNT Stock Performance
XTNT Stock Chart
XTNT Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to XTNT. When comparing the yearly performance of all stocks, XTNT turns out to be only a medium performer in the overall market: it outperformed 66.5% of all stocks.
XTNT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to XTNT. Both the profitability and financial health of XTNT have multiple concerns.
XTNT Earnings
On November 10, 2025 XTNT reported an EPS of 0.01 and a revenue of 33.26M. The company beat EPS expectations (296.08% surprise) and missed revenue expectations (-0.3% surprise).
XTNT Forecast & Estimates
8 analysts have analysed XTNT and the average price target is 1.53 USD. This implies a price increase of 146.38% is expected in the next year compared to the current price of 0.621.
For the next year, analysts expect an EPS growth of 121.25% and a revenue growth 12.6% for XTNT
XTNT Groups
Sector & Classification
XTNT Financial Highlights
Over the last trailing twelve months XTNT reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 107.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.43% | ||
| ROE | -9.44% | ||
| Debt/Equity | 0.46 |
XTNT Ownership
XTNT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 27.78 | 54.466B | ||
| COO | COOPER COS INC/THE | 13.98 | 13.642B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.27 | 11.706B | ||
| SOLV | SOLVENTUM CORP | 10.16 | 11.582B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.72 | 5.136B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.88 | 4.157B | ||
| ICUI | ICU MEDICAL INC | 15.21 | 3.107B | ||
| HAE | HAEMONETICS CORP/MASS | 11.15 | 2.784B | ||
| XRAY | DENTSPLY SIRONA INC | 7.87 | 2.305B | ||
| NEOG | NEOGEN CORP | 26.8 | 1.977B | ||
| UFPT | UFP TECHNOLOGIES INC | 20 | 1.572B | ||
| STAA | STAAR SURGICAL CO | 133.29 | 937.102M | ||
| BVS | BIOVENTUS INC - A | 11.04 | 713.391M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About XTNT
Company Profile
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.
Company Info
IPO: 2010-06-30
XTANT MEDICAL HOLDINGS INC
664 Cruiser Lane
Belgrade Montana MONTANA 59714 US
CEO: Sean E. Browne
Employees: 217
Phone: 14063880480
XTANT MEDICAL HOLDINGS INC / XTNT FAQ
Can you describe the business of XTANT MEDICAL HOLDINGS INC?
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.
What is the current price of XTNT stock?
The current stock price of XTNT is 0.621 USD. The price increased by 2.87% in the last trading session.
Does XTANT MEDICAL HOLDINGS INC pay dividends?
XTNT does not pay a dividend.
What is the ChartMill rating of XTANT MEDICAL HOLDINGS INC stock?
XTNT has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of XTANT MEDICAL HOLDINGS INC (XTNT) based on its PE ratio?
The PE ratio for XTANT MEDICAL HOLDINGS INC (XTNT) is 62.1. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 0.621 USD.
Can you provide the number of employees for XTANT MEDICAL HOLDINGS INC?
XTANT MEDICAL HOLDINGS INC (XTNT) currently has 217 employees.